1. Home
  2. IRDM vs PTGX Comparison

IRDM vs PTGX Comparison

Compare IRDM & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iridium Communications Inc

IRDM

Iridium Communications Inc

HOLD

Current Price

$52.74

Market Cap

5.7B

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$130.12

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRDM
PTGX
Founded
2000
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
6.4B
IPO Year
2007
2016

Fundamental Metrics

Financial Performance
Metric
IRDM
PTGX
Price
$52.74
$130.12
Analyst Decision
Hold
Strong Buy
Analyst Count
6
13
Target Price
$29.80
$108.23
AVG Volume (30 Days)
3.5M
727.2K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
1.65%
N/A
EPS Growth
12.77
N/A
EPS
0.20
0.05
Revenue
$871,659,000.00
N/A
Revenue This Year
$3.18
$874.25
Revenue Next Year
$2.50
N/A
P/E Ratio
$268.75
$2,632.40
Revenue Growth
4.93
N/A
52 Week Low
$15.65
$50.49
52 Week High
$57.18
$131.87

Technical Indicators

Market Signals
Indicator
IRDM
PTGX
Relative Strength Index (RSI) 60.05 75.18
Support Level $17.20 $94.48
Resistance Level $53.83 N/A
Average True Range (ATR) 2.99 4.88
MACD 0.88 1.40
Stochastic Oscillator 73.22 88.64

Price Performance

Historical Comparison
IRDM
PTGX

About IRDM Iridium Communications Inc

Iridium Communications Inc is the commercial provider of communications services offering true globalised coverage, connecting people, organizations, and assets to and from anywhere, in real time. The company is a provider of mobile voice and data communications services through a constellation of low-earth-orbiting satellites. Iridium's solutions are ideally suited for industries such as maritime, aviation, government/military, emergency/humanitarian services, mining, forestry, oil and gas, heavy equipment, transportation, and utilities. Iridium also provides service to subscribers from the U.S. Department of Defense, as well as other civil and government agencies world-wide. The Company operates in one business segment, providing satellite communications services and products.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: